Methylthioninium chloride - PREXA SANTE
Alternative Names: PrexaBlu; Product-118; Sublingual Methylene blueLatest Information Update: 28 Nov 2023
Price :
$50 *
At a glance
- Originator Prexa Sante
- Class Antidementias; Antidotes; Antimalarials; Antiparkinsonians; Antiseptics; Antivirals; Diagnostic agents; Dimethylamines; Phenothiazines; Small molecules
- Mechanism of Action Monoamine oxidase inhibitors; Synuclein inhibitors; Tau protein inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for phase-I development in COVID-2019-infections in Mexico (SC)
- 13 Apr 2021 PREXA SANTE announces intention to submit IND to the US FDA for COVID-2019 infections in 2021
- 13 Apr 2021 PREXA SANTE plans a clinical trial for COVID-2019 infections in USA and other countries (SC) in 2021